News

ImaCor Inc. will be showcasing for the first time Zura EVO1, its all-in-one platform for advanced hemodynamic management, at three annual scientific meetings.

Home January 16, 2015
Home
News

Non-contrast enhanced MR angiography (MRA) techniques have attracted interest in the medical community for diagnosing renal artery stenosis, as it eliminates the need for contrast agents used with computed tomography angiography (CTA).

Home January 16, 2015
Home
News

The Society of Interventional Radiology (SIR) unveiled a new brand for the society and its research organization, the SIR Foundation.

Home January 15, 2015
Home
News

At Medanta Hospital in Gurgaon, India, five EchoBox devices were connected to five GE Vivid ultrasound systems, streaming live echo images over the Web to experienced sonographers located in the United States. The sonographers were members of the American Society of Echocardiography, and were able to view the images in real-time as they were being scanned. This novel approach enabled remote imaging training for eight Indian physicians during live patient examinations.

Home January 15, 2015
Home
News

Oxford Performance Materials Inc. (OPM) announced the commencement of an extensive joint research program with Yale University to develop innovative and cost-effective 3-D printed biomedical technologies and applications.

Home January 15, 2015
Home
News

X-ray phase tomography is an imaging technique that uses penetrating X-rays to create volumetric views through "slices" or sections of soft biological tissues, such as tumors, and it offers strongly enhanced contrast compared to conventional CT scans.

Home January 15, 2015
Home
News

The OptoWire and OptoMonitor are Opsens’ products for FFR measurements to optimize the diagnosis and guide the therapy in patients with coronary heart disease.

Home January 14, 2015
Home
Feature

More than 10 percent of patients treated with aspirin therapy for primary cardiovascular disease prevention were likely inappropriately prescribed medication, according to a new study in the Journal of the American College of Cardiology that examined practice variations in aspirin therapy.

Home January 14, 2015
Home
ultrasound, market, cardiovascular, 3-D, 4-D, United States, U.S.
Feature

According to a new report by iData Research, ultrasound equipment providers in the United States are likely to see stable, reliable growth in the coming years. Already a billion-dollar industry in the U.S., the ultrasound imaging equipment market is projected to pass the $2 billion mark by 2020.

Home January 14, 2015
Home
News

University Hospitals (UH) Case Medical is now offering a new, non-invasive test for coronary artery disease designed to help physicians develop the right treatment plan for each patient. Developed by HeartFlow Inc., computed tomography-fractional flow reserve (CT-FFR) is a non-invasive imaging technology specifically designed to offer insight on both the extent of the blockage, as well as whether it is impacting blood flow to the heart. UH Case Medical Center’s Daniel Simon, M.D., will be first to use the CT-FFR test in the United States.

Home January 14, 2015
Home
News

Our daily diet may help lower bad cholesterol, in turn reducing risk for heart disease, according to health researchers in the Jan. 7 edition of the Journal of the American Heart Association. Avocados are known to be a nutrient-dense food, high in monounsaturated fatty acids. Previous studies have suggested that avocados are a cholesterol-lowering food, but this is the first study — to the researchers' knowledge — to look at health implications of avocados beyond monounsaturated fatty acids.

Home January 13, 2015
Home
Technology

Ambry Genetics announces the launch of cardiovascular genetic testing panels for inherited cardiomyopathies and arrhythmias. These feature an intuitive, tiered approach to testing for hypertrophic cardiomyopathy, long QT syndrome and Brugada syndrome.

Home January 13, 2015
Home
Technology

Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with non-valvular atrial fibrillation (NVAF).

Home January 13, 2015
Home
News

Lithoplasty is a balloon-based technology that utilizes integrated lithotripsy to disrupt both superficial and deep calcium and normalize vessel wall compliance prior to low-pressure balloon dilatation.

Home January 13, 2015
Home
News

ECRI Institute’s 2015 Top 10 Hospital C-Suite Watch List, available as a free public service, answers key questions on new and emerging health technologies that potentially provide new ways to treat patients, improve care and reduce costs.

Home January 13, 2015
Home
Subscribe Now